- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
0
Posted on 5/25/26 at 11:42 am to omegaman66
quote:That is what's happening.
Just say no.
But again, it cannot happen at the previous European price point.
Posted on 5/25/26 at 11:53 am to SlowFlowPro
quote:
What else would you expect from a website with the URL amgreatness.com?
What do you suggest? Should the US allow Europe to fix prices on US imports at below cost, thus causing Americans to pick up the tab? Is that what you call "free trade"? We're subsidizing their healthcare system, forcing the cost onto US consumers and the US govt, while also running massive trade deficits with Europe, partly due to their byzantine system of regulations. Congress won't do a thing about our trade issues, and when Trump tries to impose tariffs, "Free Trade" and "Higher Prices" are the rallying cry from his opponents.
Here's what our politicians should do, IMO. Tell the drug producers, here and abroad, that they must charge Americans the lowest cost for their product that any other country receives. And tell them to bring a proportional amount of their manufacturing to the US. If they won't do that, then Congress should act to support Trump's punitive tariffs. It's past time to end the uneven trade that's hollowing out the US economy, destroying US jobs and making us dependent on critical imports.
This post was edited on 5/25/26 at 12:38 pm
Posted on 5/25/26 at 11:53 am to NC_Tigah
quote:
quote:
Just say no.
That is what's happening.
But again, it cannot happen at the previous European price point.
So if we are saying no they would be paying the same price. We are selling low to them because they won't pay higher. So no, it isn't happening.
Posted on 5/25/26 at 12:27 pm to omegaman66
quote:It is.
So if we are saying no they would be paying the same price. We are selling low to them because they won't pay higher. So no, it isn't happening.
That's why you see R&D articles like this appearing, lamenting how the poor ole Europeans can't pay full price.
quote:
LINK
Posted on 5/25/26 at 12:30 pm to omegaman66
quote:
Europe is not forcing anyone to lower the cost without the seller agreeing to it.
Actually, that is exactly what they are doing
Posted on 5/25/26 at 12:43 pm to udtiger
How is Europe forcing companies to sale to the at certain prices when those companies could simply refuse to sale at those prices?
Posted on 5/25/26 at 12:49 pm to omegaman66
quote:
How is Europe forcing companies to sale to the at certain prices when those companies could simply refuse to sale at those prices?
When a company develops a drug, a large part of the cost is upfront R&D cost, which occurs years/decades in advance of any ROI. When you include the time value of money, that's a very large invesment. Once a drug is on the market, the R&D is a sunk cost. The cost of actually producing and distributing a drug, especially small molecules, is relatively low. So companies will accede to government pricing demands because they still earn a small "profit" at those lower prices. But US consumers who pay full price are paying for the R&D costs.
The EU isn't forcing the manufacturers to sell their product in Europe. The EU is forcing US consumers to pay for an inordinate portion of the high cost of drug R&D.
This post was edited on 5/25/26 at 1:05 pm
Posted on 5/25/26 at 1:11 pm to omegaman66
quote:Until this year, state-ownership in Europe would negotiate its price for a drug offering, state-ownership in Canada would negotiate its price, and eventually pharma would tag the US private market (pharmacies, clinics, hospitals, etc) with the residual transference costs. Companies could negotiate those costs around the edges.
How is Europe forcing companies to sale to the at certain prices when those companies could simply refuse to sale at those prices?
But without state-run healthcare negotiating for an entire country, and with pharma lobbying to prevent US access to the cheaper cost-basis of identical foreign marketed products, US system costs were far higher.
Legal obstacles were thrown at CMS regarding price negotiations as well. We seem to have wiggled past that nonsense at least somewhat. The Inflation Reduction Act established a first-ever albeit marginally effective mechanism for Medicare to directly negotiate drug prices.
Then Trump kicked the door in last year with a "Most Favored Nation" drug pricing approach. Trump's order ties US prescription drug costs to prices in similarly developed countries. If European countries pay less for a drug than Americans, the US price must match the lowest price among peer nations. It necessitates pharma companies either raise European prices, accept lower US prices, or work some combination.
What we are seeing now is the European state-run systems simply denying their populations access to certain drugs deemed too expensive. Which is their health provision model in general.
Page 3 of 3
Popular
Back to top
Follow TigerDroppings for LSU Football News